Publications
Complete publication list (Pubmed search) :
>> Link Representative publications :
Comparison of stable human Treg and Th clones by transcriptional profiling.
Stockis J, Fink W, François V, Connerotte T, de Smet C, Knoops L, van der Bruggen P, Boon T, Coulie PG, Lucas S.
Eur J Immunol. 2009 Mar;39(3):869-82.
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora J-P, Renauld J-C, Boon T
J Exp Med. 1994, 180: 35-42.
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
Coulie P, Lehmann F, Lethé B, Herman J, Lurquin C, Andrawis M, Boon T.
Proc Natl Acad Sci USA. 1995, 92: 7976-7980.
Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor.
Ikeda H, Lethé B, Lehmann F, Van Baren N, Baurain J-F, De Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG.
Immunity. 1997, 6: 199-208
A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.
Lucas S., Brasseur F., and Boon T.
Cancer Res 1999, 59: 4100-4103.
MAGE-B5, MAGE-B6, MAGE-C2 and MAGE-C3 : four new members of the MAGE family with tumor-specific expression.
Lucas S., De Plaen E., and Boon T.
Int J Cancer 2000, 87: 55-60.
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.
Coulie PG, Karanikas V, Colau D, Lurquin C, Landry C, Marchand M, Dorval T, Brichard V, Boon T.
Proc Natl Acad Sci USA. 2001, 98: 10290-95.
An overview of the MAGE gene family with the identificaion of all human members of the family.
Chomez P., De Backer O., Bertrand M., De Plaen E., Boon T. and Lucas S.
Cancer Res 2001, 61: 5544-51.
High frequency of anti-tumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.
Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, Vigneron N, Brasseur F, Lethé, De Plaen E, Velu T, Boon, Coulie PG.
J Exp Med. 2005, 201: 241-248.
IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms.
Lucas S., Ghilardi N., Li J., de Sauvage F.J.
Proc Natl Acad Sci USA. 2003, 100: 15047-52.
